Landiolol for managing atrial fibrillation in intensive care

Landiolol is an injectable ultrashort acting beta-blocker with high beta1 selectivity indicated for heart rate control of atrial fibrillation in the emergency and critical care setting. Accordingly, landiolol is associated with a significantly reduced risk of arterial hypotension and negative inotro...

Descripción completa

Detalles Bibliográficos
Autores principales: Rehberg, Sebastian, Joannidis, Michael, Whitehouse, Tony, Morelli, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909768/
https://www.ncbi.nlm.nih.gov/pubmed/30188960
http://dx.doi.org/10.1093/eurheartj/sux039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909768/
https://www.ncbi.nlm.nih.gov/pubmed/30188960
http://dx.doi.org/10.1093/eurheartj/sux039

Ejemplares similares